Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion
Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion
Not yet recruiting · NCT06089369 · Registry updated 2024-04-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Not yet recruiting | Phase 3 | 2024-04-30 | NCT06089369 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tongji Hospital | 276 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 71 |